Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Alimta

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Alimta was produced by Lilly.

Eli Lilly, Innovent showcase Tyvyt data in first-line NSCLC

Eli Lilly, Innovent showcase Tyvyt data in first-line NSCLC

Eli Lilly and Innovent have released the detailed results from a phase 3 study of their PD-L1 inhibitor Tyvyt in combination with Alimta in first-line non-small cell lung ... In the 397-patient ORIENT-11 trial, Tyvyt (sintilimab) and Alimta (pemetrexed)

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial

Lilly’s pegilodecakin fails in long-shot pancreatic cancer trial Lilly’s presence in cancer is led by lung cancer chemotherapy drug Alimta (pemetrexed), which brought in $2.1bn in sales last year down from a peak of around $2.8bn

Lilly scores FDA okay for Cyramza in liver cancer

Lilly scores FDA okay for Cyramza in liver cancer Last year sales rose 8% to around $820m making it Lilly’s second-largest cancer drug after $2bn lung cancer blockbuster Alimta (pemetrexed), but it has come under pressure as a

Trulicity’s ascent lifts Lilly

Trulicity’s ascent lifts Lilly The company also recently gained FDA approval for Alimta in combination with Keytruda and platinum chemotherapy for the first-line treatment of patients with metastatic NSCLC with no EGFR or ALK

EMA says Lilly’s Lartruvo should not be prescribed

EMA says Lilly’s Lartruvo should not be prescribed The product was viewed as an important element in Lilly’s efforts to prop up its oncology franchise after the loss of patent protection for blockbuster Alimta (pemetrexed) in some markets,

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Frontera Group

Welcome to Frontera Group, where our agencies immerse you in the world of the patient...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics